SCHEMBL30122007

SCHEMBL30122007

COC(=O)c1cc(F)cc(OCC(=O)OC(C)(C)C)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36
▸ MTNR1A P48039 1/20 0.36
▸ MTNR1B P49286 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ MAPT P10636 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24744882 1.00 ALDH1A1 (0.37) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL24745723 0.88 ALDH1A1 (0.36) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL31443911 0.85 ALDH1A1 (0.39) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL24744883 0.84 MTNR1A (0.34) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL20510109 0.83 FFAR4 (0.52) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL24745568 0.80 HPGD (0.39) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL21834936 0.78 CHEK1 (0.41) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL20766728 0.76 KDM4E (0.47) ALDH1A1HPGDMEN1KMT2AKDM4E
SCHEMBL29346885 0.75 MRGPRX4 (0.42) ALDH1A1HPGDMEN1KMT2APOLB
SCHEMBL24745340 0.74 ALOX5AP (0.36) ALDH1A1HPGDMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347579-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2024-04-10 — — EP disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
Send feedback